Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Endocrine 4Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Multiple Myeloma 130Neoplasms, Plasma Cell 16Recurrence 14Lymphoma 10Neoplasms 9Immunoglobulin Light-chain Amyloidosis 8Monoclonal Gammopathy of Undetermined Significance 5Leukemia, Plasma Cell 5Hematologic Neoplasms 5Waldenstrom Macroglobulinemia 3Smoldering Multiple Myeloma 3Paraproteinemias 3Leukemia 3Respiratory Aspiration 2Ovarian Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Hypoventilation 2Gastrointestinal Neoplasms 2Disease 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Amyloidosis 2Venous Thromboembolism 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Taste Disorders 1

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroid Carcinoma, Anaplastic × Plasma cell × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡